Urooj Namra, Abubakar Muhammad, Asghar Kashif, Hassan Muhammad, Malik Awais Amjad, Rehman Bushra, Sajjad Bakra, Farooqi Nifasat, Chaudhry Zulqarnain, Parvaiz Asad, Khan Amina
Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Department of Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
J Cancer Allied Spec. 2024 Jan 22;10(1):559. doi: 10.37029/jcas.v10i1.559. eCollection 2024.
Breast-conserving surgery (BCS) has been historically linked with a high rate of re-excision. To address this issue, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) developed consensus guidelines in 2014 to standardize practices and improve clinical outcomes for BCS patients. In our tertiary cancer care hospital, we assessed the impact of these guidelines on the re-excision rate following BCS.
We conducted a retrospective study on breast cancer patients who underwent BCS at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan. The study compared the re-excision rate before the implementation of the SSO-ASTRO consensus guidelines (November 2015-July 2017) and after the implementation (January 2018-August 2019). Margins were considered positive if "ink on tumor" was present and negative if "no ink on tumor" was present. Fisher's exact test or Chi-square test was used to compare the re-excision rates between the pre- and post-guideline periods.
A total of 919 patients were identified, with 533 from the pre-guideline period and 386 from the post-guideline period. Of the 919 patients, 31 with ductal carcinoma (DCIS) were excluded from the re-excision analysis because the guidelines were not implemented on the DCIS. Furthermore, the overall rate of re-excision in our data was 4.3%. The re-excision rate decreased from 71.1% to 28.9% ( ≤ 0.05) following the adoption of the guidelines. We observed a statistically significant decrease in the re-excision rate after implementing the SSO-ASTRO guidelines.
Implementation of the SSO-ASTRO margin guidelines led to a notable decrease in the overall re-excision rate in our data set. These findings suggest that continued adherence to the guidelines may lead to a further reduction in the re-excision rate in the future.
保乳手术(BCS)历来与高再次切除率相关。为解决这一问题,外科肿瘤学会(SSO)和美国放射肿瘤学会(ASTRO)于2014年制定了共识指南,以规范操作并改善BCS患者的临床结局。在我们的三级癌症护理医院,我们评估了这些指南对BCS术后再次切除率的影响。
我们对在巴基斯坦拉合尔的肖卡特·汗姆纪念癌症医院和研究中心接受BCS的乳腺癌患者进行了一项回顾性研究。该研究比较了SSO-ASTRO共识指南实施前(2015年11月至2017年7月)和实施后(2018年1月至2019年8月)的再次切除率。如果存在“肿瘤上有墨水”,则切缘被视为阳性;如果存在“肿瘤上无墨水”,则切缘被视为阴性。使用Fisher精确检验或卡方检验比较指南实施前后的再次切除率。
共识别出919例患者,其中533例来自指南实施前,386例来自指南实施后。在这919例患者中,31例导管原位癌(DCIS)患者被排除在再次切除分析之外,因为该指南未在DCIS上实施。此外,我们数据中的总体再次切除率为4.3%。采用指南后,再次切除率从71.1%降至28.9%(P≤0.05)。我们观察到实施SSO-ASTRO指南后再次切除率有统计学意义的下降。
SSO-ASTRO切缘指南的实施导致我们数据集中总体再次切除率显著下降。这些发现表明,持续遵循这些指南可能会在未来进一步降低再次切除率。